WhyPeptides

ClinicalTrials.gov research-record information

ClinicalTrials.gov research records

ClinicalTrials.gov research-record snapshot for New York, NY

Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 7 results; after an exact city/state check of listed facilities, 7 records were retained for New York, New York. It is not a clinic, enrollment, or local-availability directory.

Snapshot methodology and exact-location matching

City/state source filter
New York, New York
Exact-location inclusion rule
A listed facility city and state must match New York, New York.

Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.

Fixed query terms

  • semaglutide
  • tirzepatide
  • cagrilintide
  • retatrutide
  • tesamorelin
  • sermorelin
  • ipamorelin
  • bpc-157
  • thymosin alpha 1
  • pt-141

Included study statuses

  • RECRUITING
  • NOT_YET_RECRUITING
  • ACTIVE_NOT_RECRUITING
  • ENROLLING_BY_INVITATION

How to read this snapshot

Research-record limits

All retained records

Study-level status mix

The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.

RECRUITING
4 records
NOT_YET_RECRUITING
0 records
ACTIVE_NOT_RECRUITING
3 records
ENROLLING_BY_INVITATION
0 records

Records in this snapshot

Retained ClinicalTrials.gov NCT records

The retrieved source snapshot contains 7 exact-location records and 6 listed facilities. All 7 retained records are shown below.

NCT06937086

Registry title: Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Icahn School of Medicine at Mount SinaiNew York, New York 10029
  • New York Gastroenterology AssociatesNew York, New York 10075

NCT06937099

Registry title: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • New York Gastroenterology AssociatesNew York, New York 10075

NCT07165028

Registry title: A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • NYU Langone HealthNew York, New York 10016
  • IMA Clinical Research ManhattanNew York, New York 10036
  • New York Gastroenterology AssociatesNew York, New York 10075

NCT06383390

Registry title: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • NYU Langone HealthNew York, New York 10016
  • Icahn School of Medicine at Mount SinaiNew York, New York 10029

NCT05669755

Registry title: REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • IMA Clinical Research- NYNew York, New York 10036

NCT05390892

Registry title: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Naomi Berrie Diabetes Center at New York Presbyterian-Columbia UniversityNew York, New York 10032

NCT06662383

Registry title: A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • New York Gastroenterology AssociatesNew York, New York 10075

Source retrieval and snapshot limits

Source-query results versus exact-location records

At retrieval, the fixed ClinicalTrials.gov source query returned 7 results. After an exact city/state check of listed facilities, 7 records were retained for New York, New York, across 6 listed facilities. All 7 retained records are shown on this page.

Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Source-query results
7
Exact-location records retained
7
Listed facilities retained
6
Records shown
7 of 7
Fixed ClinicalTrials.gov source query (JSON) Broader live ClinicalTrials.gov search (no status filter)

Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.

Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.